IRF4 and plasma cell myeloma: It is 7–12 times more effective at suppressing multiple myeloma cell growth and 6–15 times more potent at inhibiting the NF‐κB, PI3K/AKT, JAK/STAT3, and IRF4 pathways than curcumin [35].